Applied DNA Sciences Inc. reported consolidated earnings results for the second quarter ended March 31, 2013. For the quarter, the company generated $344,605 in revenues from operations principally from the sales of authentication services. For the three months ended March 31, 2012, the company generated $518,402 in revenues from operations. The decrease in sales for the three months ended March 31, 2013 compared to the three months ended March 31, 2012 was primarily caused by the completion of its prior R&D contract with the Logistics Management Institute, and a slower than anticipated replacement of that revenue by DNA-marking contracts with commercial electronics manufacturers. Net loss increased to $3,127,631 from a net loss of $1,543,882 for the three months ended March 31, 2012.

Applied DNA Sciences Inc. announced that it has entered into a 2-way exclusive agreement with SmokeCloak, A/S of Agerhatten 25, Odense, Denmark, to market a technology combining APDN's SigNature DNA in a rapid-deployment security smoke called DNA Fog. The agreement calls for mutual exclusivity: MSS will buy DNA only from APDN, while APDN will supply DNA to no other fog manufacturer than SmokeCloak. As part of the relationship, MSS has extended their distribution network for use by APDN, accessing security sales throughout the world and enhancing APDN's internal sales force. The SmokeCloak anti-intruder device deploys in a crime attempt, filling a room with a fog sometimes called a security smoke that virtually immobilizes criminals and now also will mark a criminal with APDN's SigNature DNA so it may be used to forensically link the criminal to the crime. The DNA Fog product will be used in the SmokeCloak VALI product range and can be combined with APDN's existing SmartDNA anti-intruder device, currently used in Sweden and the U.S. The combination of SmokeCloak's room-filling smoke generators together with APDN's anti-intruder device, which produces a targeted spray directed at the suspect, will give both companies a strong competitive edge in the crime deterrent market.

Applied DNA Sciences Inc., Q2 2013 Earnings Call, May 16, 2013